Imunon, Inc.
Pharmaceutical company · Lawrenceville, New Jersey, United States · Nasdaq: IMNN
Imunon, Inc. is a pharmaceutical company headquartered in Lawrenceville, New Jersey, United States. Its shares trade on Nasdaq under the ticker IMNN. The US FDA lists 1 drug manufacturing or testing site registered to the company. It has reported private securities offerings to the US SEC, most recently $3.3 million sold in a notice filed in 2025.
Imunon at a glance
What does Imunon do?
Operations at its FDA-registered drug sites
Private fundraising reported to the SEC
6 Form D notices; the most recent reported $3.3 million sold (2025).
Where is Imunon located?
Headquarters: Lawrenceville, New Jersey, United States
- Huntsville, AlabamaCelsion · FDA drug site
Frequently asked questions about Imunon
Where is Imunon headquartered?
Imunon, Inc. is headquartered in Lawrenceville, New Jersey, United States.
What does Imunon do?
Imunon, Inc. is a pharmaceutical company. Its FDA-registered drug sites are registered for analysis, API manufacturing, manufacturing and relabeling. Its SEC industry classification is Pharmaceutical Preparations.
Is Imunon a public company?
Yes. Imunon, Inc. trades on Nasdaq under the ticker IMNN.
Similar companies
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
- Marker Therapeutics, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.